These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7518997)

  • 1. New antipsychotic agent, risperidone, introduced.
    Am J Hosp Pharm; 1994 May; 51(9):1145. PubMed ID: 7518997
    [No Abstract]   [Full Text] [Related]  

  • 2. Risperidone: integrating research and practice.
    Addington D
    Br J Hosp Med; 1994 Sep 7-20; 52(5):223-4. PubMed ID: 7529628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serotonin antagonism involved in the antipsychotic effect. Confirmation with ritanserine and risperidone].
    Niemegeers CJ; Awouters F; Janssen PA
    Encephale; 1990; 16(2):147-51. PubMed ID: 1693560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic interaction between risperidone and clozapine.
    Tyson SC; Devane CL; Risch SC
    Am J Psychiatry; 1995 Sep; 152(9):1401-2. PubMed ID: 7544547
    [No Abstract]   [Full Text] [Related]  

  • 5. Risperidone: review of its pharmacology and therapeutic use in schizophrenia.
    Gupta S; Black DW; Smith DA
    Ann Clin Psychiatry; 1994 Sep; 6(3):173-80. PubMed ID: 7533585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA approved new drug bulletin: risperidone (risperdal).
    RN; 1994 Jun; 57(6):45-6. PubMed ID: 7526438
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects.
    Huang ML; Van Peer A; Woestenborghs R; De Coster R; Heykants J; Jansen AA; Zylicz Z; Visscher HW; Jonkman JH
    Clin Pharmacol Ther; 1993 Sep; 54(3):257-68. PubMed ID: 7690693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacological, pharmacokinetic and clinical overview of risperidone, a new antipsychotic that blocks serotonin 5-HT2 and dopamine D2 receptors.
    He H; Richardson JS
    Int Clin Psychopharmacol; 1995 Mar; 10(1):19-30. PubMed ID: 7542676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of risperidone in humans: a summary.
    Heykants J; Huang ML; Mannens G; Meuldermans W; Snoeck E; Van Beijsterveldt L; Van Peer A; Woestenborghs R
    J Clin Psychiatry; 1994 May; 55 Suppl():13-7. PubMed ID: 7520903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief comparison of the pharmacokinetics and pharmacodynamics of the traditional and newer antipsychotic drugs.
    DeVane CL
    Am J Health Syst Pharm; 1995 Feb; 52(3 Suppl 1):S15-8. PubMed ID: 7538435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone: neurochemical, pharmacologic and clinical properties of a new antipsychotic drug.
    Keegan D
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S46-52. PubMed ID: 7533051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptics and the immune system.
    Nyulassy S; Jahnová E; Keleová A
    Cesk Psychiatr; 1993 Jan; 89(1):30-4. PubMed ID: 7685246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antipsychotic drugs: how do their receptor-binding profiles compare?
    Richelson E
    J Clin Psychiatry; 2010 Sep; 71(9):1243-4. PubMed ID: 20923625
    [No Abstract]   [Full Text] [Related]  

  • 14. Risperidone.
    Cohen LJ
    Pharmacotherapy; 1994; 14(3):253-65. PubMed ID: 7524043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A PET study of D2 and 5-HT2 receptor occupancy induced by risperidone in poor metabolizers of debrisoquin and risperidone.
    Nyberg S; Dahl ML; Halldin C
    Psychopharmacology (Berl); 1995 Jun; 119(3):345-8. PubMed ID: 7545821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of risperidone in chronic schizophrenic patients.
    Borison RL; Diamond B; Pathiraja A; Meibach RC
    Psychopharmacol Bull; 1994; 30(2):193-7. PubMed ID: 7530379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of risperidone].
    Remr J
    Cesk Psychiatr; 1993 Jan; 89(1):18-9. PubMed ID: 7685245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone and breast-feeding.
    Aichhorn W; Stuppaeck C; Whitworth AB
    J Psychopharmacol; 2005 Mar; 19(2):211-3. PubMed ID: 15728443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat.
    van Beijsterveldt LE; Geerts RJ; Leysen JE; Megens AA; Van den Eynde HM; Meuldermans WE; Heykants JJ
    Psychopharmacology (Berl); 1994 Feb; 114(1):53-62. PubMed ID: 7531352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations of risperidone and 9-OH risperidone following intramuscular injection of long-acting risperidone compared with oral risperidone medication.
    Nesvåg R; Hendset M; Refsum H; Tanum L
    Acta Psychiatr Scand; 2006 Jul; 114(1):21-6. PubMed ID: 16774657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.